$350M raisedMergerHealthcare & Life Sciences
Alaunos acquires Paragon spinout Velaris in a reverse merger
Alaunos Therapeutics acquired Velaris Therapeutics in a reverse merger, alongside a Fairmount-led private placement of about $350M.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Get healthcare deals like this every morning
The day's biggest deals in five minutes. Free, with no paywalled links.